M. Baba, S. Yakubo, E. Fukuda, Yukiko Ueda, Tomohiro Hattori, E. Shiba, M. Soma, Y. Arashima, T. Namiki
{"title":"系统评价:汉方“yokukan - sanka - chimpii - hange”对痴呆行为和心理症状的影响","authors":"M. Baba, S. Yakubo, E. Fukuda, Yukiko Ueda, Tomohiro Hattori, E. Shiba, M. Soma, Y. Arashima, T. Namiki","doi":"10.4172/2327-5162.1000254","DOIUrl":null,"url":null,"abstract":"Introduction: Randomized usual-case controlled studies on Japanese dementia patients with behavioral and psychological symptoms were conducted to examine the effects of Kampo medicine Yokukan-San (YKS) on the behavioral and psychological symptoms of dementia (BPSD). These studies showed that YKS is effective in treating BPSD. Yokukan-San-Ka-Chimpi-Hange is a Kampo medicine made by adding dried citrus peel and pinellia tuber to YKS. In Japan, we usually administer Yokukan-San-Ka-Chimpi-Hange as Kracie Yokukan-San-Ka-Chimpi-Hange extract granules (KB-83), produced by Kracie Pharma, Ltd. (Tokyo, Japan). \nMethods: We investigated 3 trials carried out on the use of KB-83 for the treatment of severe dementia in elderly. \nResults: KB-83 showed no change in core symptoms after administration in cases of dementia, but significant improvements in BPSD were reported. KB-83 was particularly effective in treating aggressive symptoms such as restlessness or abusive language. \nConclusion: In the treatment of dementia, we think that the administration of KB-83 is effective in mitigating the BPSD, and that further studies are need to investigate the effects of EK-83.","PeriodicalId":90094,"journal":{"name":"Alternative & integrative medicine","volume":" ","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2327-5162.1000254","citationCount":"0","resultStr":"{\"title\":\"Systematic Review: Effects of the Kampo Formula Yokukan-San-Ka-Chimpi-Hange on Behavioral and Psychological Symptoms of Dementia\",\"authors\":\"M. Baba, S. Yakubo, E. Fukuda, Yukiko Ueda, Tomohiro Hattori, E. Shiba, M. Soma, Y. Arashima, T. Namiki\",\"doi\":\"10.4172/2327-5162.1000254\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Randomized usual-case controlled studies on Japanese dementia patients with behavioral and psychological symptoms were conducted to examine the effects of Kampo medicine Yokukan-San (YKS) on the behavioral and psychological symptoms of dementia (BPSD). These studies showed that YKS is effective in treating BPSD. Yokukan-San-Ka-Chimpi-Hange is a Kampo medicine made by adding dried citrus peel and pinellia tuber to YKS. In Japan, we usually administer Yokukan-San-Ka-Chimpi-Hange as Kracie Yokukan-San-Ka-Chimpi-Hange extract granules (KB-83), produced by Kracie Pharma, Ltd. (Tokyo, Japan). \\nMethods: We investigated 3 trials carried out on the use of KB-83 for the treatment of severe dementia in elderly. \\nResults: KB-83 showed no change in core symptoms after administration in cases of dementia, but significant improvements in BPSD were reported. KB-83 was particularly effective in treating aggressive symptoms such as restlessness or abusive language. \\nConclusion: In the treatment of dementia, we think that the administration of KB-83 is effective in mitigating the BPSD, and that further studies are need to investigate the effects of EK-83.\",\"PeriodicalId\":90094,\"journal\":{\"name\":\"Alternative & integrative medicine\",\"volume\":\" \",\"pages\":\"1-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-11-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4172/2327-5162.1000254\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alternative & integrative medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2327-5162.1000254\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative & integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2327-5162.1000254","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
引言:对有行为和心理症状的日本痴呆症患者进行随机常规病例对照研究,以检验Kampo medicine Yokukan San(YKS)对痴呆症行为和心理特征(BPSD)的影响。这些研究表明YKS治疗BPSD是有效的。Yokukan San Ka Chimpi Hange是一种贡布药,通过在YKS中加入干柑橘皮和菠萝块茎制成。在日本,我们通常以Kracie Yokukan-San-Ka-Chimpi-Hange提取物颗粒(KB-83)的形式给药,该颗粒由Kracie Pharma,有限公司生产。方法:我们研究了KB-83治疗老年严重痴呆的3项试验。结果:KB-83在痴呆患者给药后核心症状没有变化,但BPSD有显著改善。KB-83在治疗烦躁不安或辱骂性语言等攻击性症状方面尤其有效。结论:在痴呆症的治疗中,我们认为给予KB-83可以有效地减轻BPSD,需要进一步研究EK-83的作用。
Systematic Review: Effects of the Kampo Formula Yokukan-San-Ka-Chimpi-Hange on Behavioral and Psychological Symptoms of Dementia
Introduction: Randomized usual-case controlled studies on Japanese dementia patients with behavioral and psychological symptoms were conducted to examine the effects of Kampo medicine Yokukan-San (YKS) on the behavioral and psychological symptoms of dementia (BPSD). These studies showed that YKS is effective in treating BPSD. Yokukan-San-Ka-Chimpi-Hange is a Kampo medicine made by adding dried citrus peel and pinellia tuber to YKS. In Japan, we usually administer Yokukan-San-Ka-Chimpi-Hange as Kracie Yokukan-San-Ka-Chimpi-Hange extract granules (KB-83), produced by Kracie Pharma, Ltd. (Tokyo, Japan).
Methods: We investigated 3 trials carried out on the use of KB-83 for the treatment of severe dementia in elderly.
Results: KB-83 showed no change in core symptoms after administration in cases of dementia, but significant improvements in BPSD were reported. KB-83 was particularly effective in treating aggressive symptoms such as restlessness or abusive language.
Conclusion: In the treatment of dementia, we think that the administration of KB-83 is effective in mitigating the BPSD, and that further studies are need to investigate the effects of EK-83.